| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A disease activity index: Its use in clinical trials and disease assessment in patients with rheumatoid arthritis
|
Davis, M.J.
|
|
1993
|
|
2S1 |
p. 50-56
7 p.
|
artikel
|
| 2 |
A double-blind comparison of parenteral methotrexate and parenteral gold in the treatment of early erosive rheumatoid arthritis: An interim report on 102 patients after 12 months
|
Rau, R.
|
|
1991
|
|
2S1 |
p. 13-20
8 p.
|
artikel
|
| 3 |
Analgesic effects of prostaglandin synthesis inhibition by diclofenac sodium
|
Kral, John G.
|
|
1985
|
|
2S1 |
p. 93-96
4 p.
|
artikel
|
| 4 |
An editor's liaison with indomethacin
|
Talbott, John H.
|
|
1982
|
|
2S1 |
p. 97-99
3 p.
|
artikel
|
| 5 |
Antiinflammatory activity of indomethacin in clinical practice
|
Hart, F.Dudley
|
|
1982
|
|
2S1 |
p. 103-104
2 p.
|
artikel
|
| 6 |
Antiinflammatory therapy: Pre-indomethacin
|
Rothermich, Norman O.
|
|
1982
|
|
2S1 |
p. 81-84
4 p.
|
artikel
|
| 7 |
Appraisal of efficacy and tolerability of INDOCIN® (Indomethacin, MSD) in acute gout and moderate to severe ankylosing spondylitis
|
Calabro, John J.
|
|
1982
|
|
2S1 |
p. 112-116
5 p.
|
artikel
|
| 8 |
Clinical application of indomethacin: Efficacy and tolerability
|
Plotz, Charles M.
|
|
1982
|
|
2S1 |
p. 100-102
3 p.
|
artikel
|
| 9 |
Comparing the strengths and weaknesses of observational and experimental studies using a postmarketing surveillance study as a protypic example
|
Furst, Daniel E.
|
|
1993
|
|
2S1 |
p. 57-61
5 p.
|
artikel
|
| 10 |
Compliance
|
Katz, Warren A.
|
|
1982
|
|
2S1 |
p. 132-135
4 p.
|
artikel
|
| 11 |
Current concepts in the rheumatic diseases: Etiology and treatment
|
Hart, Francis Dudley
|
|
1985
|
|
2S1 |
p. 4-7
4 p.
|
artikel
|
| 12 |
Determination of the stereoisomers of hydroxychloroquine and its major metabolites in plasma and urine following a single oral administration of racemic hydroxychloroquine
|
Iredale, Joanna
|
|
1993
|
|
2S1 |
p. 74-81
8 p.
|
artikel
|
| 13 |
Diclofenac in the treatment of ankylosing spondylitis: Review of worldwide clinical experience and report of a double-blind comparison with indomethacin
|
Khan, Muhammad Asim
|
|
1985
|
|
2S1 |
p. 80-84
5 p.
|
artikel
|
| 14 |
Diclofenac in the treatment of painful joints and traumatic tendinitis (including strains and sprains): A brief review
|
Machtey, Israel
|
|
1985
|
|
2S1 |
p. 87-92
6 p.
|
artikel
|
| 15 |
Diclofenac sodium in the treatment of rheumatoid arthritis and osteoarthritis
|
Caldwell, Jacques R.
|
|
1985
|
|
2S1 |
p. 73-79
7 p.
|
artikel
|
| 16 |
Early, aggressive therapy for rheumatoid arthritis: Concerns, descriptions, and estimate of outcome
|
Wilke, William S.
|
|
1993
|
|
2S1 |
p. 26-41
16 p.
|
artikel
|
| 17 |
Evaluation of sustained-release indomethacin in osteoarthritis
|
Gengos, Don C.
|
|
1982
|
|
2S1 |
p. 142-146
5 p.
|
artikel
|
| 18 |
INDOCIN® SR (Indomethacin, MSD) in the treatment of moderate to severe rheumatoid arthritis
|
Hart, C.B.
|
|
1982
|
|
2S1 |
p. 147-151
5 p.
|
artikel
|
| 19 |
Indomethacin and indomethacin sustained release—A comparison of their pharmacokinetic profiles
|
Yeh, Kuang C.
|
|
1982
|
|
2S1 |
p. 136-141
6 p.
|
artikel
|
| 20 |
Indomethacin in acute painful shoulder bursitis and/or tendinitis
|
Calabro, John J.
|
|
1982
|
|
2S1 |
p. 130-131
2 p.
|
artikel
|
| 21 |
Indomethacin in the 1970s
|
Stevenson, Carl R.
|
|
1982
|
|
2S1 |
p. 107-108
2 p.
|
artikel
|
| 22 |
Introduction
|
Rothermich, Norman O.
|
|
1982
|
|
2S1 |
p. 77-
1 p.
|
artikel
|
| 23 |
Introduction
|
Paulus, Harold E.
|
|
1993
|
|
2S1 |
p. 1-
1 p.
|
artikel
|
| 24 |
Introduction: The art and science of nonsteroidal anti-inflammatory drug selection
|
Gottlieb, Norman L.
|
|
1985
|
|
2S1 |
p. 1-3
3 p.
|
artikel
|
| 25 |
Introduction: The place of methotrexate in the treatment of rheumatoid arthritis
|
Hoffmeister, Rex T.
|
|
1991
|
|
2S1 |
p. 1-3
3 p.
|
artikel
|
| 26 |
Inverting the therapeutic pyramid: Observations and recommendations on new directions in rheumatoid arthritis therapy based on the author's experience
|
Wilske, Kenneth R.
|
|
1993
|
|
2S1 |
p. 11-18
8 p.
|
artikel
|
| 27 |
Limitations of randomized clinical trials to recognize possible advantages of combination therapies in rheumatic diseases
|
Pincus, Theodore
|
|
1993
|
|
2S1 |
p. 2-10
9 p.
|
artikel
|
| 28 |
Long-term experience with indomethacin in active stages of moderate to severe rheumatoid arthritis and moderate to severe osteoarthritis
|
Lockie, L.Maxwell
|
|
1982
|
|
2S1 |
p. 109-111
3 p.
|
artikel
|
| 29 |
Marine sponge aggregation: A model for effects of NSAIDs on the calcium movements of cell activation
|
Weissmann, Gerald
|
|
1985
|
|
2S1 |
p. 42-53
12 p.
|
artikel
|
| 30 |
Mechanism of action of hydroxychloroquine as an antirheumatic drug
|
Fox, Robert I.
|
|
1993
|
|
2S1 |
p. 82-91
10 p.
|
artikel
|
| 31 |
Mechanisms of cartilage degradation: Relation to choice of therapeutic agent
|
Cooke, Theodore Derek Vernon
|
|
1985
|
|
2S1 |
p. 16-23
8 p.
|
artikel
|
| 32 |
Panel discussion I
|
|
|
1985
|
|
2S1 |
p. 14-15
2 p.
|
artikel
|
| 33 |
Panel Discussion II
|
|
|
1985
|
|
2S1 |
p. 54-56
3 p.
|
artikel
|
| 34 |
Panel discussion III
|
|
|
1985
|
|
2S1 |
p. 85-86
2 p.
|
artikel
|
| 35 |
Panel Discussion IV
|
|
|
1985
|
|
2S1 |
p. 97-98
2 p.
|
artikel
|
| 36 |
Pathogenesis of osteoarthritis and use of diclofenac in the treatment of experimental models
|
Pelletier, Jean-Pierre
|
|
1985
|
|
2S1 |
p. 24-28
5 p.
|
artikel
|
| 37 |
Pathogenesis of rheumatoid arthritis: Basis for future therapies
|
Wortmann, Robert L.
|
|
1991
|
|
2S1 |
p. 35-39
5 p.
|
artikel
|
| 38 |
Personal experience in the treatment of seropositive rheumatoid arthritis with drugs used in combination
|
McCarty, Daniel J.
|
|
1993
|
|
2S1 |
p. 42-49
8 p.
|
artikel
|
| 39 |
Pharmacology of diclofenac sodium (Voltaren®)
|
Scholer, Dietrich W.
|
|
1985
|
|
2S1 |
p. 61-64
4 p.
|
artikel
|
| 40 |
Prognostic staging for therapy of rheumatoid arthritis
|
Willkens, Robert F.
|
|
1991
|
|
2S1 |
p. 40-43
4 p.
|
artikel
|
| 41 |
Prostaglandin research: Clinical implications
|
Kuehl, Jr., Frederick A.
|
|
1982
|
|
2S1 |
p. 119-125
7 p.
|
artikel
|
| 42 |
Prostaglandins, thromboxanes, and leukotrienes in inflammation
|
Malmsten, Curt L.
|
|
1985
|
|
2S1 |
p. 29-35
7 p.
|
artikel
|
| 43 |
Protocol development for combination therapy with disease-modifying antirheumatic drugs
|
Paulus, Harold E.
|
|
1993
|
|
2S1 |
p. 19-25
7 p.
|
artikel
|
| 44 |
Special studies of diclofenac and safety: Gastrointestinal, renal, hepatic, and other consequences of therapy
|
Roth, Sanford H.
|
|
1985
|
|
2S1 |
p. 99-104
6 p.
|
artikel
|
| 45 |
Synovial fluid concentrations of diclofenac in patients with rheumatoid arthritis or osteoarthritis
|
Benson, Merrill D.
|
|
1985
|
|
2S1 |
p. 65-67
3 p.
|
artikel
|
| 46 |
The advent of INDOCIN® (Indomethacin, MSD): Impact on clinical medicine
|
Smyth, Charley J.
|
|
1982
|
|
2S1 |
p. 94-96
3 p.
|
artikel
|
| 47 |
The discovery of indomethacin and the proliferation of NSAIDs
|
Shen, T.Y.
|
|
1982
|
|
2S1 |
p. 89-93
5 p.
|
artikel
|
| 48 |
The effects of diclofenac sodium on arachidonic acid metabolism
|
Ku, Edmond C.
|
|
1985
|
|
2S1 |
p. 36-41
6 p.
|
artikel
|
| 49 |
The history of diclofenac
|
Sallmann, Alfred R.
|
|
1985
|
|
2S1 |
p. 57-60
4 p.
|
artikel
|
| 50 |
The immunologic basis of chronic inflammatory disease
|
Rosenthal, Alan S.
|
|
1982
|
|
2S1 |
p. 126-129
4 p.
|
artikel
|
| 51 |
The ocular safety of hydroxychloroquine
|
Easterbrook, Michael
|
|
1993
|
|
2S1 |
p. 62-67
6 p.
|
artikel
|
| 52 |
Therapeutic significance of laboratory results in rheumatic disease
|
Wright, Verna
|
|
1985
|
|
2S1 |
p. 8-13
6 p.
|
artikel
|
| 53 |
Therapy for rheumatoid arthritis: Combinations of disease-modifying drugs and new paradigms of treatment
|
Wilke, William S.
|
|
1991
|
|
2S1 |
p. 21-34
14 p.
|
artikel
|
| 54 |
The relative toxicity of alternative therapies for rheumatoid arthritis: Implications for the therapeutic progression
|
Fries, James F.
|
|
1993
|
|
2S1 |
p. 68-73
6 p.
|
artikel
|
| 55 |
The search for antiinflammatory activity
|
Winter, C.A.
|
|
1982
|
|
2S1 |
p. 85-88
4 p.
|
artikel
|
| 56 |
Worldwide clinical safety experience with diclofenac
|
Willkens, Robert F.
|
|
1985
|
|
2S1 |
p. 105-110
6 p.
|
artikel
|
| 57 |
Worldwide experience with diclofenac in rheumatoid arthritis and osteoarthritis
|
Macauley, David
|
|
1985
|
|
2S1 |
p. 68-72
5 p.
|
artikel
|
| 58 |
Worldwide trends in the socioeconomic impact and long-term prognosis of rheumatoid arthritis
|
Markenson, Joseph A.
|
|
1991
|
|
2S1 |
p. 4-12
9 p.
|
artikel
|
Tijdschrift beschrijving